7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 
      
    		                     
      operating activities
    		                     
      net income
    		33,400,000 41,100,000 19,500,000 139,300,000 72,200,000 54,500,000 28,500,000 19,200,000 46,500,000 36,800,000 20,400,000 38,500,000 46,400,000 15,000,000 -13,200,000 -13,700,000 -13,800,000 4,500,000 -51,000,000 -21,300,000 -9,900,000 
      adjustments to reconcile net income to net cash from operating activities
    		                     
      depreciation and amortization
    		125,100,000 88,400,000 85,200,000 83,500,000 77,300,000 69,700,000 66,100,000 61,900,000 55,100,000 50,000,000 47,600,000 47,500,000 42,600,000 29,900,000 29,100,000 27,600,000 25,800,000 25,700,000 25,300,000 24,100,000 24,300,000 
      equity-based compensation expense
    		15,600,000 15,200,000 26,000,000 14,100,000 14,300,000 14,300,000 22,800,000 11,000,000 12,400,000 13,100,000 20,900,000 11,200,000 12,200,000 9,300,000 16,900,000 13,900,000 6,300,000 6,600,000 14,000,000 10,000,000 6,200,000 
      revaluation of contingent liabilities
    		-2,800,000 -900,000 -3,700,000 100,000 1,500,000 300,000 2,100,000 1,600,000 8,900,000 5,600,000 7,000,000 600,000 -36,900,000   0 0 0 200,000 -200,000 1,100,000 
      gain on investments in securities
    		  -300,000                   
      change in tra liability
    		200,000 800,000 -3,000,000 -5,200,000 289,400,000 3,600,000 1,200,000 600,000 1,500,000 800,000 500,000 600,000          
      amortization of capitalized financing costs, net of premium accretion
    		2,900,000                     
      loss on extinguishment of debt
    		9,200,000               0 0 0 200,000 9,500,000 0 
      benefit from bad debts
    		1,800,000 1,900,000 4,100,000 100,000 2,500,000 2,100,000 1,800,000 1,800,000 1,900,000 2,300,000 3,200,000 4,200,000 1,500,000 1,300,000 3,000,000 1,000,000 2,200,000 1,400,000 6,700,000 800,000 1,500,000 
      deferred income taxes
    		13,500,000 -2,800,000 -17,700,000 -21,900,000 -290,800,000   500,000 -200,000 -2,800,000 -5,600,000 2,300,000 1,100,000 800,000 -6,300,000 1,800,000 -2,000,000 -2,200,000 -100,000 -2,400,000 1,500,000 
      unrealized foreign exchange losses
    		800,000                     
      other noncash items
    		   200,000 500,000 -500,000 -1,100,000 0 1,200,000 0 300,000 0 200,000 400,000 300,000 -300,000 500,000 200,000 300,000 400,000 -200,000 
      change in operating assets and liabilities
    		                     
      accounts receivable
    		17,100,000 -39,200,000 15,200,000 -29,000,000 -9,200,000 -37,300,000 500,000 -8,900,000 -5,900,000 -20,800,000 -17,100,000 62,200,000 -8,600,000 -29,500,000 -20,000,000 -22,700,000 -6,000,000 -51,300,000 -40,700,000 0 -24,100,000 
      prepaid expenses and other assets
    		-700,000 5,300,000 -4,000,000 8,600,000 -4,200,000 -5,800,000 -8,500,000 -1,400,000 -4,500,000 -1,000,000 100,000 3,100,000 -6,300,000 1,100,000 600,000       
      capitalized customer acquisition costs
    		-18,300,000 -13,200,000 -9,000,000 -9,100,000 -10,900,000 -9,600,000 -9,500,000 -8,600,000 -9,300,000 -9,000,000 -7,300,000 -5,800,000          
      accounts payable
    		-16,500,000 7,600,000 9,400,000 0 -11,800,000 15,300,000 21,400,000 -1,100,000 -3,800,000 14,300,000 5,300,000 -6,900,000 8,400,000 20,400,000 15,400,000 -2,600,000 8,300,000 22,800,000 28,000,000 -18,900,000 10,300,000 
      accrued expenses and other liabilities
    		-10,000,000 27,100,000 -23,600,000 6,600,000 11,700,000 17,700,000 6,100,000 -17,000,000 9,200,000             
      payments on contingent liabilities in excess of initial fair value
    		0   -11,100,000 0 0 -300,000 -15,000,000              
      right-of-use assets and lease liabilities
    		-200,000 -100,000 -100,000 -100,000 -200,000 -200,000 -200,000 -200,000 0 0 100,000 100,000 -100,000         
      deferred revenue
    		700,000 -1,200,000 -4,900,000 -4,900,000 3,100,000 -7,000,000 -6,300,000 -5,400,000 -1,200,000 -5,100,000 4,200,000 -4,600,000 1,200,000 -3,500,000 4,700,000 -2,100,000 -2,500,000 -1,300,000 6,600,000 -1,100,000 -200,000 
      net cash from operating activities
    		171,800,000 141,900,000 96,600,000 145,400,000 182,100,000 116,100,000 56,700,000 105,300,000 111,700,000 91,900,000 79,400,000 139,500,000 50,900,000 47,900,000 37,100,000 3,600,000 20,600,000 6,700,000 -1,700,000 6,400,000 10,300,000 
      capex
    		-31,200,000 -18,700,000 -18,200,000 -17,100,000 -16,900,000 -16,800,000 -14,700,000 -14,800,000 -11,400,000 -7,200,000 -10,700,000 -11,000,000 -11,400,000 -12,300,000 -8,000,000 -8,000,000 -4,700,000 -4,700,000 -3,600,000 -2,700,000 -1,900,000 
      free cash flows
    		140,600,000 123,200,000 78,400,000 128,300,000 165,200,000 99,300,000 42,000,000 90,500,000 100,300,000 84,700,000 68,700,000 128,500,000 39,500,000 35,600,000 29,100,000 -4,400,000 15,900,000 2,000,000 -5,300,000 3,700,000 8,400,000 
      investing activities
    		                     
      acquisitions, net of cash acquired
    		-2,564,600,000 0 -3,700,000 -248,700,000 -4,500,000   -133,400,000 0 -35,100,000 -1,200,000 -100,000 -122,600,000 0 -12,600,000 -300,000 -14,000,000 400,000 -40,600,000   
      acquisition of equipment to be leased
    		-36,100,000 -23,200,000 -30,300,000 -25,400,000 -29,500,000 -22,000,000 -24,400,000 -15,100,000 -25,700,000 -22,300,000 -14,700,000 -14,200,000 -14,700,000 -15,000,000 -9,900,000 -10,600,000 -16,400,000 -8,500,000 -10,400,000 -8,700,000  
      capitalized software development costs
    		-31,200,000 -18,700,000 -18,200,000 -17,100,000 -16,900,000 -16,800,000 -14,700,000 -14,800,000 -11,400,000 -7,200,000 -10,700,000 -11,000,000 -11,400,000 -12,300,000 -8,000,000 -8,000,000 -4,700,000 -4,700,000 -3,600,000 -2,700,000 -1,900,000 
      acquisition of property, plant and equipment
    		-6,400,000 -900,000 -1,500,000 -1,600,000 -2,000,000 -2,200,000 -1,300,000 -2,400,000 -5,200,000 -3,400,000 -2,700,000 -1,200,000 -5,000,000 -800,000 -1,000,000 -1,900,000 -1,300,000 -4,300,000 -700,000 -2,200,000 -1,200,000 
      deposits with sponsor bank
    		0 0 -26,800,000                   
      residual commission buyouts
    		-11,200,000 -6,100,000 -1,800,000 -12,200,000 -2,300,000 -400,000 -900,000 0 -800,000 -6,600,000 -2,100,000 -7,300,000 -256,400,000 -7,200,000 -4,600,000 -6,000,000 -3,500,000 -100,000 -800,000 -1,800,000 -1,700,000 
      proceeds from sale of investments in securities
    		1,000,000 1,700,000 300,000 122,300,000 1,500,000 1,000,000 1,600,000               
      investments in securities
    		0 0 -3,000,000         0 0 0 -1,500,000 -1,000,000 0 -13,500,000 -16,000,000   
      net cash from investing activities
    		-2,648,500,000 -47,200,000 -85,000,000 -255,900,000 -53,700,000 -341,800,000 -39,700,000 -150,800,000 -43,100,000 -76,600,000 -31,400,000 -33,800,000 -395,900,000 -43,200,000 -43,900,000 -34,700,000 -46,500,000 -38,000,000 -77,500,000 -70,200,000 -15,200,000 
      financing activities
    		                     
      proceeds from long-term debt
    		1,000,000,000   0            0      
      proceeds from preferred stock
    		0                     
      repayment of debt
    		0               0 0 0 -900,000 -450,800,000 -900,000 
      deferred financing costs
    		-27,600,000   -2,100,000        0 0 -100,000 -4,800,000 -100,000 -14,800,000 0 -400,000 -22,700,000  
      settlement line of credit
    		0 0 26,800,000                   
      settlement activity
    		-28,900,000 -3,600,000 -25,500,000 69,200,000 39,600,000 4,300,000 -58,300,000               
      proceeds from common stock
    		                     
      global blue shares purchased through squeeze-out merger
    		                     
      repurchases of class a common stock
    		0 -85,300,000 -62,900,000 -110,000,000 -20,000,000   -8,600,000              
      payments for withholding tax related to vesting of restricted stock units
    		-4,000,000 -1,000,000 -17,800,000 -15,200,000 -6,400,000 -2,100,000 -9,100,000 -7,400,000 -4,800,000 -10,400,000 -5,300,000 -2,500,000 -400,000 -8,000,000 -12,200,000 -5,900,000 -3,400,000 -113,900,000 -2,400,000   
      payments of preferred dividends
    		                     
      payments on contingent liabilities
    		-200,000   -4,200,000 -600,000 -800,000 -100,000 -10,500,000 -3,800,000 -200,000 -300,000         -300,000 -300,000 
      distributions to noncontrolling interests
    		-100,000 -18,600,000 -100,000 -13,200,000 -4,600,000 -1,700,000 -300,000 -200,000 -500,000 -800,000 -1,400,000           
      net change in bank deposits
    		   0 0 -50,500,000 -20,300,000               
      other financing activities
    		-100,000 -1,100,000 -1,200,000 -4,700,000                  
      net cash from financing activities
    		965,100,000 1,706,800,000 -80,700,000 -21,400,000 1,051,400,000 -71,000,000 -29,800,000 -27,900,000 -9,100,000 -108,200,000 -7,000,000 -3,200,000 -400,000 -175,300,000 -35,700,000 -25,500,000 614,300,000 -113,900,000 -3,700,000 662,700,000 89,800,000 
      effect of exchange rate changes on cash and cash equivalents and restricted cash
    		-31,800,000 67,300,000 14,800,000 -24,900,000 12,300,000 -2,500,000 -6,500,000 11,900,000 -1,500,000 300,000 400,000           
      change in cash and cash equivalents and restricted cash
    		-1,543,400,000 1,868,800,000 -54,300,000 -156,800,000 1,192,100,000 -299,200,000 -19,300,000 -61,500,000 58,000,000 -92,600,000 41,400,000           
      cash and cash equivalents and restricted cash, beginning of period
    		0 0 1,438,600,000  0 0 721,800,000               
      cash and cash equivalents and restricted cash, end of period
    		-1,543,400,000 1,868,800,000 1,384,300,000  1,192,100,000 -299,200,000 702,500,000               
      see accompanying notes to unaudited condensed consolidated financial statements.
    		                     
      amortization of capitalized financing costs
    		  3,500,000 2,700,000 2,500,000 2,000,000 2,100,000 2,100,000 2,100,000 2,000,000 2,100,000 2,100,000 2,100,000 2,000,000 1,900,000  1,700,000 1,200,000 1,200,000  800,000 
      unrealized foreign exchange gains
    		    1,300,000 -400,000 -1,400,000               
      impairment of intangible assets
    		                     
      inventory
    		   1,300,000 4,100,000 2,200,000 700,000 1,500,000 3,200,000 1,800,000 700,000 -300,000 200,000 1,200,000 1,700,000 -1,100,000 -100,000 2,900,000 100,000 1,100,000 0 
      purchase of intangible assets
    		       0 0             
      cash and cash equivalents and restricted cash - beginning of period
    		                     
      cash and cash equivalents and restricted cash - end of period
    		                     
      cash paid for interest
    		                     
      cash paid for income taxes, net of refunds
    		                     
      unrealized gain on investments in securities
    		    -10,800,000 200,000 -11,000,000 -700,000 -2,600,000 0 -8,900,000           
      repurchases of class a common stock to treasury stock
    		           0 0 -167,200,000 -18,700,000       
      cash and cash equivalents and restricted cash
    		                     
      beginning of period
    		         0 776,500,000  0 0 1,231,500,000  0 0 927,800,000 0 0 
      end of period
    		         -92,600,000 817,900,000  -345,500,000 -170,800,000 1,189,000,000  588,400,000 -145,200,000 844,900,000 598,900,000 84,900,000 
      supplemental cash flows information and noncash activities are further described in note 22.
    		                     
      accrued expenses and other current liabilities
    		          5,900,000 -200,000 5,200,000 0 3,100,000 -200,000 100,000 -1,200,000 6,400,000 200,000 1,200,000 
      impact of lease modifications
    		                   0 0 
      ipo proceeds, net of underwriting discounts and commissions
    		                   0 0 
      proceeds from private placement
    		                   0 0 
      september 2020 follow-on offering proceeds, net of underwriting discounts and commissions
    		                     
      proceeds from revolving line of credit
    		                   0 0 
      repayment of revolving line of credit
    		                   0 0 
      offering costs
    		                   400,000  
      preferred return on preferred stock
    		                   0 0 
      capital distributions
    		                   0 0 
      effect of exchange rate changes on cash and cash equivalents
    		           1,300,000 -100,000         
      change in cash and cash equivalents
    		           103,800,000 -345,500,000 -170,800,000 -42,500,000 -56,600,000 588,400,000 -145,200,000 -82,900,000 598,900,000  
      cash and cash equivalents - beginning of period
    		                     
      cash and cash equivalents - end of period
    		                     
      cash and cash equivalents
    		                     
      supplemental cash flows information and noncash activities are further described in note 21.
    		                     
      customer acquisition costs
    		             -7,900,000 -6,300,000 -6,900,000 -6,600,000 -7,300,000 -5,400,000 -5,000,000 -4,600,000 
      supplemental cash flows information and noncash activities are further described in note 20.
    		                     
      adjustment to reconcile net income to net cash from operating activities
    		                     
      right of use assets and liabilities
    		              -100,000       
      amortization of capitalized financing costs and debt discount
    		                     
      contract assets
    		                   0 0 
      prepaid expenses and other current assets
    		                 -2,700,000 1,100,000 1,700,000 -2,200,000 
      right of use assets and liabilities net
    		                     
      september follow-on offering proceeds, net of underwriting discounts and commissions
    		                     
      principal repayments of capital leases
    		                     
      impairment on software development costs
    		                    0 
      acquisition
    		                     
      follow-on offering proceeds, net of underwriting discounts and commissions
    		                     
      payments for offering costs
    		                     
      change in cash
    		                     
      cash
    		                     
      supplemental disclosures of cash flow information
    		                     
      cash paid for income taxes
    		                     
      noncash financing activities
    		                     
      accrued preferred return on redeemable preferred units
    		                     
      contingent consideration settled with class a common stock
    		                     
      short-term financing for directors and officers insurance
    		                     
      preferred return on preferred stock settled with llc interests
    		                     
      noncash operating activity
    		                     
      deferred compensation settled with restricted stock units
    		                     
      1.
    		                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.